ESLA

Estrella Immunopharma, Inc.

Healthcare · Biotechnology

$83.31 sample

+0.91 (+1.10%) 1D

Market cap

$256.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-25

Alerts

8

Price$83.31 +19.87% 3M daily closessample

83.3169.50

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: General Counsel
Oct 02INSInsider sell: EVP, Operations
Sep 25SEC8-K filed: material event
Sep 18INSInsider sell: Chief Executive Officer
Sep 11SEC10-Q filed
Sep 04SEC10-Q filed
Aug 27INSInsider buy: Director
Aug 19INSInsider sell: 10% owner

Sign up to see the real ESLA record →

Company facts

SEC EDGAR registration

Name: Estrella Immunopharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +38sample, -100 to +100
Reporting currency: USD

Who is positioning in ESLA

sample

Insiders: 33 insider transactions over 90 days, net selling, $824.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 13 funds hold $3.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.4B +18.8% y/y

Q4 2024Q3 2026

Inventory$7.2B +7.1% y/y

Q4 2024Q3 2026

Accounts receivable$5.6B +12.6% y/y

Q4 2024Q3 2026

Total debt$15.2B +14.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $77.7B +3.2% 3M
Sample peer B: $168.4B +6.6% 3M
Sample peer C: $56.9B +7.0% 3M
Sample peer D: $143.6B +14.0% 3M
Sample peer E: $81.8B +15.8% 3M